Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Yesterday's big volume on the TSX
View:
Post by SPCEO1 on Jul 22, 2021 9:56am

Yesterday's big volume on the TSX

I suspect the reason we saw big volume yesterday on the TSX (beating the volume on NASDAQ for the first time in recent memory) is because TH was likely speaking with analysts and portfolio managers in Canada the last couple of days and now is moving to the US via Cantor. Whenever they put out a new corporate presentation, you pretty much know they are starting an analyst/PM tour. 

Given that TH has now sorted out its strategy re: cancer and NASH, an analyst/PM tour makes sense to explain that. Apparently, they got at least one or two Canadian institutions they visited with to buy, which is good. Hopefully, they have even better success in the US. And even more hopefully, they will get the Cantor analyst to pick up coverage on them. If some of Cantor's clients are intrigued by what they hear today, that will certainly increase the odds of Cantor picking up coverage, but those odds are likely still not fantastic.
Comment by palinc2000 on Jul 22, 2021 10:20am
I agree,,,If they are able  in private meetings to convince institutions and brokerage houses ahead of releasing news then as BFW posted yesterday volume comes before price.....Volume breeds volume and price follows volume,,,,,,,Thus far they have not been very successful in selling the story but maybe now the toolbox has  the right tools,,,,If you cant convince investors in private ...more  
Comment by qwerty22 on Jul 22, 2021 11:34am
It's almost like they've now remembered to do what they forgot to do for the past 2 years. Having said that though it definitely feels like we are reaching a turning point. You identified the company going through a transition, with all the changes Paul is implimenting it feels almost like a re-structuring. Maybe that's over-stating things. With clarity on the R&D assets and ...more  
Comment by Wino115 on Jul 22, 2021 12:36pm
Sometimes it takes an outsiders objective view to finally convince a company of the merits and pitfalls of their various business strategies and how they should frame and discuss them broadly and to the market.  PL probably brought some of that along and maybe he needed LSA as the outsider to push it to a new level, which the new pitch surely is.  It could be it was mostly the LSA   ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities